Ragusi, M. A., Bismeijer, T., Velden, B. H. v. d., Loo, C. E., Canisius, S., Wesseling, J., . . . Gilhuijs, K. G. (2021). Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients. Elsevier.
Cita Chicago Style (17a ed.)Ragusi, Max A.A., Tycho Bismeijer, Bas H.M. van der Velden, Claudette E. Loo, Sander Canisius, Jelle Wesseling, Lodewyk F.A Wessels, Sjoerd G. Elias, y Kenneth G.A Gilhuijs. Contralateral Parenchymal Enhancement on MRI Is Associated with Tumor Proteasome Pathway Gene Expression and Overall Survival of Early ER+/HER2-breast Cancer Patients. Elsevier, 2021.
Cita MLA (8a ed.)Ragusi, Max A.A., et al. Contralateral Parenchymal Enhancement on MRI Is Associated with Tumor Proteasome Pathway Gene Expression and Overall Survival of Early ER+/HER2-breast Cancer Patients. Elsevier, 2021.